Draft Guidance Webinar: FDA/CBER's Consensus Standards Recognition Program
This webinar will explain the new CBER guidance on concensus standards and SCB will coordinate participants comments
The FDA recently released guidance on its new CBER standards recognition program, which will help regenerative medicine stakeholders identify standards FDA will accept in regulatory submissions.
The Standards Coordinating Body for Regenerative Medicine (SCB) will be hosting a Webinar on August 24, 2022 at 12:00pm EST to explain the guidance and coordinate comments from industry which are due back to the FDA on September, 14th 2022.
This webinar will explain the new CBER guidance on concensus standards and SCB will coordinate participants comments
The FDA recently released guidance on its new CBER standards recognition program, which will help regenerative medicine stakeholders identify standards FDA will accept in regulatory submissions.
The Standards Coordinating Body for Regenerative Medicine (SCB) will be hosting a Webinar on August 24, 2022 at 12:00pm EST to explain the guidance and coordinate comments from industry which are due back to the FDA on September, 14th 2022.